Ligand validation:2VMD

1PG: 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VMD_1PG_A_502	41%	67%	0.143	0.923	0.64	0.62	-	-	0	0	65%	1
2VMD_1PG_A_503	16%	75%	0.211	0.888	0.57	0.4	-	-	0	0	41%	1
2VMC_1PG_A_502	57%	81%	0.091	0.928	0.58	0.25	-	-	0	0	65%	1
9JTT_1PG_B_602	98%	80%	0.063	0.984	0.4	0.45	-	-	18	0	100%	1
9KCS_1PG_A_613	94%	80%	0.066	0.964	0.38	0.47	-	-	3	0	100%	0.5
2WN3_1PG_A_500	89%	69%	0.078	0.957	0.46	0.72	-	-	0	0	100%	1
9KCT_1PG_A_612	84%	82%	0.082	0.944	0.36	0.44	-	-	2	0	100%	0.5
2ZNW_1PG_B_243	79%	72%	0.098	0.943	0.59	0.48	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.